PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16325423-2	2006	CDO catalyzes the first step in the pathway of taurine synthesis from cysteine as well as the first step in the catabolism of cysteine to pyruvate and sulfate.	Sulfates	151-158	cysteine dioxygenase type 1	Rattus norvegicus	0-3	
16855246-2	2006	In these organisms, CDO plays an important role in the homeostatic regulation of steady-state cysteine levels and provides important oxidized metabolites of cysteine such as sulfate and taurine.	Sulfates	174-181	cysteine dioxygenase type 1	Rattus norvegicus	20-23	
12421853-1	2002	In liver, cysteine dioxygenase (CDO), cysteinesulfinate decarboxylase (CSD), and gamma-glutamylcysteine synthetase (GCS) play important regulatory roles in the metabolism of cysteine to sulfate, taurine and glutathione.	Sulfates	186-193	cysteine dioxygenase type 1	Rattus norvegicus	10-30	
12421853-1	2002	In liver, cysteine dioxygenase (CDO), cysteinesulfinate decarboxylase (CSD), and gamma-glutamylcysteine synthetase (GCS) play important regulatory roles in the metabolism of cysteine to sulfate, taurine and glutathione.	Sulfates	186-193	cysteine dioxygenase type 1	Rattus norvegicus	32-35	
11433432-1	2001	Cysteine dioxygenase (CDO) converts cysteine to cysteinesulphinic acid and is the rate-limiting step in sulphate production.	Sulfates	104-112	cysteine dioxygenase type 1	Rattus norvegicus	22-25	
11140370-5	2000	Changes in CDO and GCS were associated with changes in cysteine catabolism to taurine plus sulfate and in synthesis of glutathione, respectively.	Sulfates	91-98	cysteine dioxygenase type 1	Rattus norvegicus	11-14	
11474229-1	2001	BACKGROUND/AIMS: Cysteine dioxygenase (CDO, EC 1.13.11.20) catalyses the conversion of cysteine to cysteine sulphinic acid and controls the rate-limiting step of sulphate production.	Sulfates	162-170	cysteine dioxygenase type 1	Rattus norvegicus	17-37	
11474229-1	2001	BACKGROUND/AIMS: Cysteine dioxygenase (CDO, EC 1.13.11.20) catalyses the conversion of cysteine to cysteine sulphinic acid and controls the rate-limiting step of sulphate production.	Sulfates	162-170	cysteine dioxygenase type 1	Rattus norvegicus	39-42	
11474229-2	2001	Many neurological and non-neurological diseases are associated with abnormalities in CDO activity, giving rise to reduced availability of sulphate.	Sulfates	138-146	cysteine dioxygenase type 1	Rattus norvegicus	85-88	
9824269-8	1998	CONCLUSIONS: These results suggest that the 68 kDa Type II is the predominant isoform in vitro and in vivo and that its centrilobular localisation may allow CDO to initiate the production of sulphate and taurine for Phase II conjugation in the liver.	Sulfates	191-199	cysteine dioxygenase type 1	Rattus norvegicus	157-160